Literature DB >> 14579148

Inherited variants in MYH are unlikely to contribute to the risk of lung carcinoma.

Nada Al-Tassan1, Tim Eisen, Julie Maynard, Helen Bridle, Bindiya Shah, Christina Fleischmann, Julian R Sampson, Jeremy P Cheadle, Richard S Houlston.   

Abstract

The base excision repair gene MYH protects against damage to DNA from reactive oxygen species, which are commonly found in cigarette smoke. Inherited mutations in MYH predispose to colorectal adenomas and carcinomas that show a characteristic pattern of somatic G:C-->T:A mutations in the APC gene. A similar pattern of somatic mutations in the TP53 gene is reported in smoking-related lung cancers. We therefore tested whether germline changes in MYH may also contribute to the development of lung cancer by screening for variants in 276 patients with lung carcinoma and 106 normal controls. No patients harboured truncating mutations in MYH and only a single patient was a carrier for the G382D missense mutation. We identified three common coding region (V22M, Q324H and S501F) and intronic (157+30A>G, 462+35G>A and 1435-40G>C) variants, but none were over-represented in the patient samples, indicating that MYH variants are unlikely to predispose significantly to the risk of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579148     DOI: 10.1007/s00439-003-1033-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

Review 1.  The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine).

Authors:  M L Michaels; J H Miller
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

2.  A simple approximation for calculating sample sizes for comparing independent proportions.

Authors:  J L Fleiss; A Tytun; H K Ury
Journal:  Biometrics       Date:  1980-06       Impact factor: 2.571

3.  Somatic mutations and single nucleotide polymorphisms of base excision repair genes involved in the repair of 8-hydroxyguanine in damaged DNA.

Authors:  K Shinmura; S Yamaguchi; T Saitoh; T Kohno; J Yokota
Journal:  Cancer Lett       Date:  2001-05-10       Impact factor: 8.679

4.  Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.

Authors:  Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle
Journal:  Nat Genet       Date:  2002-01-30       Impact factor: 38.330

5.  Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk.

Authors:  Loïc Le Marchand; Timothy Donlon; Annette Lum-Jones; Ann Seifried; Lynne R Wilkens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-04       Impact factor: 4.254

Review 6.  p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.

Authors:  S P Hussain; C C Harris
Journal:  Mutat Res       Date:  1999-07-16       Impact factor: 2.433

7.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?

Authors:  D R Shopland; H J Eyre; T F Pechacek
Journal:  J Natl Cancer Inst       Date:  1991-08-21       Impact factor: 13.506

8.  Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations.

Authors:  Siân Jones; Paul Emmerson; Julie Maynard; Jacqueline M Best; Sheila Jordan; Geraint T Williams; Julian R Sampson; Jeremy P Cheadle
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

9.  p53 mutations in lung cancers from non-smoking atomic-bomb survivors.

Authors:  Y Takeshima; T Seyama; W P Bennett; M Akiyama; S Tokuoka; K Inai; K Mabuchi; C E Land; C C Harris
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

  9 in total
  13 in total

1.  Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.

Authors:  Aung Ko Win; Sean P Cleary; James G Dowty; John A Baron; Joanne P Young; Daniel D Buchanan; Melissa C Southey; Terrilea Burnett; Patrick S Parfrey; Roger C Green; Loïc Le Marchand; Polly A Newcomb; Robert W Haile; Noralane M Lindor; John L Hopper; Steven Gallinger; Mark A Jenkins
Journal:  Int J Cancer       Date:  2011-04-08       Impact factor: 7.396

Review 2.  Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine.

Authors:  Douglas M Banda; Nicole N Nuñez; Michael A Burnside; Katie M Bradshaw; Sheila S David
Journal:  Free Radic Biol Med       Date:  2017-01-10       Impact factor: 7.376

3.  Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.

Authors:  Afaf Elsaid; Rami Elshazli; Fatma El-Tarapely; Hossam Darwish; Camelia Abdel-Malak
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

4.  MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.

Authors:  Linnea M Baudhuin; Lewis R Roberts; Felicity T B Enders; Russell L Swanson; Teresa A Mettler; Ileana Aderca; Linda M Stadheim; W Edward Highsmith
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-15       Impact factor: 4.553

5.  Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients.

Authors:  Maartje Nielsen; Liza N van Steenbergen; Natalie Jones; Stefanie Vogt; Hans F A Vasen; Hans Morreau; Stefan Aretz; Julian R Sampson; Olaf M Dekkers; Maryska L G Janssen-Heijnen; Frederik J Hes
Journal:  J Natl Cancer Inst       Date:  2010-11-02       Impact factor: 13.506

6.  MYH Gene Status in Polish FAP Patients without APC Gene Mutations.

Authors:  Marzena Skrzypczak; Marta Podralska; Wolfram Heinritz; Ursula G Froster; Daniel Lipiński; Ryszard Słomski; Andrzej Pławski
Journal:  Hered Cancer Clin Pract       Date:  2006-01-15       Impact factor: 2.857

7.  MYH mutations are rare in prostate cancer.

Authors:  Eyun-Jung Shin; Edward Chappell; Vaijayanti Pethe; Karen Hersey; Theodore van der Kwast; Neil Fleshner; Bharati Bapat
Journal:  J Cancer Res Clin Oncol       Date:  2007-01-12       Impact factor: 4.322

8.  MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population.

Authors:  Aiko Miyaishi; Kayo Osawa; Yasunori Osawa; Natsuko Inoue; Kana Yoshida; Mayumi Kasahara; Akimitsu Tsutou; Yoshiki Tabuchi; Kazuo Sakamoto; Noriaki Tsubota; Juro Takahashi
Journal:  J Exp Clin Cancer Res       Date:  2009-01-22

9.  Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.

Authors:  Aung Ko Win; Jeanette C Reece; James G Dowty; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Melissa C Southey; Joanne P Young; Sean P Cleary; Hyeja Kim; Michelle Cotterchio; Finlay A Macrae; Katherine M Tucker; John A Baron; Terrilea Burnett; Loïc Le Marchand; Graham Casey; Robert W Haile; Polly A Newcomb; Stephen N Thibodeau; John L Hopper; Steven Gallinger; Ingrid M Winship; Noralane M Lindor; Mark A Jenkins
Journal:  Int J Cancer       Date:  2016-06-02       Impact factor: 7.316

10.  Protection of pulmonary epithelial cells from oxidative stress by hMYH adenine glycosylase.

Authors:  Ted M Kremer; Mikael L Rinne; Yi Xu; Xian Ming Chen; Mark R Kelley
Journal:  Respir Res       Date:  2004-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.